Editors in Conversation
Science Podcasts
Editors in Conversation is the official podcast of the American Society for Microbiology Journals. Editors in Conversation features discussions between ASM Journals Editors, researchers and clinicians working on the most cutting edge issues in the microbial sciences. Topics include laboratory diagnosis and clinical treatment of infectious diseases, antimicrobial resistance, epidemiology of infections, multidrug-resistant organisms, pharmacology of antimicrobial agents, susceptibility testing, and more. The podcast is directed to microbiologists, infectious diseases clinicians, pharmacists and basic, clinical and translational researchers interested in the microbial sciences. A particular emphasis is on basic, epidemiological and pharmacological aspects of infectious diseases, including antimicrobial resistance and therapeutics.
Location:
Washington, DC
Genres:
Science Podcasts
Description:
Editors in Conversation is the official podcast of the American Society for Microbiology Journals. Editors in Conversation features discussions between ASM Journals Editors, researchers and clinicians working on the most cutting edge issues in the microbial sciences. Topics include laboratory diagnosis and clinical treatment of infectious diseases, antimicrobial resistance, epidemiology of infections, multidrug-resistant organisms, pharmacology of antimicrobial agents, susceptibility testing, and more. The podcast is directed to microbiologists, infectious diseases clinicians, pharmacists and basic, clinical and translational researchers interested in the microbial sciences. A particular emphasis is on basic, epidemiological and pharmacological aspects of infectious diseases, including antimicrobial resistance and therapeutics.
Twitter:
@jeffandf
Language:
English
Website:
https://asm.org/podcasts
Email:
asmcomm@gmail.com
10 Years of Rhodococcus: Clinical Trends and Susceptibility Profiles
Duration:00:37:38
Why Phage Therapy May Fail
Duration:00:37:32
Is Lophomonas a Pathogen?
Duration:00:34:33
Treatment of Multidrug-resistant Tuberculosis
Duration:00:40:17
New generation B-lactam/B-lactamase inhibitors: Taniborbactam
Duration:00:47:47
Favorite Clinical Microbiology Papers of 2023 (JCM ed.)
Duration:01:05:16
Antimicrobial Resistance in Neisseria Gonorrhoeae (JCM ed.)
Duration:00:28:14
New Antifungals (AAC ed.)
Duration:00:45:49
A Novel Coccidioides Antibody LFA (JCM ed.)
Duration:00:44:00
Climate Change and Antimicrobial Resistance (AAC ed.)
Duration:00:29:26
Emerging Antifungal-Resistant Dermatophytes (JCM ed.)
Duration:00:29:26
Artificial Intelligence and Infectious Diseases (AAC ed.)
Duration:00:38:55
Viral Outbreaks in the Headlines (JCM ed.)
Duration:00:26:58
AAC Launches a New Section Focused On Antimicrobial Stewardship (AAC ed.)
Duration:00:37:14
Susceptibility Testing for Aztreonam with Ceftazidime-Avibactam (JCM ed.)
Duration:00:38:56
Hispanic Leadership in Vaccine Sciences With Dr. Maria Elena Bottazzi (AAC ed.)
Duration:00:28:42
Updates on Testing for Vaginitis/Vaginosis (JCM ed.)
Duration:00:40:37
Management of Difficult to Treat HSV and CMV Infections (AAC ed.)
Duration:00:45:45
Susceptibility Testing for Piperacillin-Tazobactam (JCM ed.)
Duration:00:49:35
Antimicrobial Resistance in Neisseria gonorrhoeae (AAC ed.)
Duration:00:44:50